Categories: News

Invivyd Announces Dosing of First Participant in CANOPY Phase 3 Pivotal Clinical Trial Investigating VYD222 for the Prevention of Symptomatic COVID-19 

Recent Posts

Hologic Joins NEST Governance Committee to Advance the Use of Real-World Data in Medical Device Evaluation

ARLINGTON, Va.--(BUSINESS WIRE)--The National Evaluation System for health Technology (NEST), an initiative of the Medical…

55 minutes ago

“Regulatory Uncertainty is Slowing Innovation: New Survey of 486 Life Science Professionals Reveals Gaps in Compliance Readiness and Confidence”

ARLINGTON, Va., June 2, 2025 /PRNewswire/ -- BioInformatics, a Science and Medicine Group company, has released…

58 minutes ago

Scripta Insights and RxSaveCard Partner to Help Self-Insured Employers Cut Prescription Drug Costs and Strengthen Fiduciary Compliance

New Collaboration Integrates Low-Cost Cash Pay Options into Scripta's Rx Navigation™ Platform, Supporting Fiduciary Responsibility…

58 minutes ago

Target ALS Chooses PacBio HiFi Sequencing to Advance ALS Research with Largest Global Genomic Study to Date

Organization's 6,000-genome effort will power global ALS research through detailed long-read sequencing data made freely…

58 minutes ago

Lilly to participate in Goldman Sachs 46th Annual Global Health Care Conference

INDIANAPOLIS, June 2, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) will participate in the…

58 minutes ago

Manufacturing PMI® at 48.5%; May 2025 Manufacturing ISM® Report On Business®

New Orders and Backlogs Contracting; Production and Employment Contracting; Supplier Deliveries Slowing; Raw Materials Inventories…

58 minutes ago